Aurora A‐Mediated Exosomal Secretion of miR ‐644a Promotes T‐Lymphocyte Apoptosis Through the NOXA / p4E ‐ BP1 / MCL ‐1 Pathway
Clinical and Experimental Pharmacology and Physiology · 2026-06 · 53 (6)
DOI: 10.1111/1440-1681.70132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, online erschienen am 27.05.2026. Verfasst von Ziyi Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Apoptosis, Exosomes, T-Lymphocytes, Myeloid Cell Leukemia Sequence 1 Protein. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Lung cancer continues to be the primary contributor to cancer‐related mortality worldwide. While immunotherapy markedly improves outcomes for many patients, clinical evidence indicates that non–small‐cell lung cancer (NSCLC) patients with elevated Aurora A expression exhibit reduced therapeutic responses to immune checkpoint blockade. Elucidating the underlying mechanisms may unlock novel strategies to enhance the clinical benefits for this subset. In this study, we characterised cellular senescence and tumour microenvironment interactions using lung cancer cell lines with different Aurora A expression levels. H23 (high Aurora A expression) and A549 (low Aurora A expression) cells were selected to model tumour‐immune crosstalk. Tumour‐infiltrating lymphocytes (TILs) were isolated and activated via anti‐CD28 costimulation. Through gain‐ and loss‐of‐function experiments, we established the optimal conditions to induce T‐lymphocyte apoptosis and identified critical cell ratios and culture durations. In these co‐culture systems, immune checkpoint inhibitors more effectively suppressed Aurora A‐low tumour growth. Mechanistically, Aurora A overexpression exacerbated T‐lymphocyte apoptosis via the NOXA‐MCL‐1 pathway. Further analysis revealed that Aurora A disrupts the eIF4G:eIF4E complex by suppressing p4E‐BP1, thereby up‐regulating the pro‐apoptotic factor NOXA while down‐regulating the anti‐apoptotic factor MCL‐1. Aurora A‐driven T‐lymphocyte apoptosis via the NOXA‐MCL‐1 axis compromises PD‐1/PD‐L1‐mediated immune responses, providing a molecular rationale for immunotherapy resistance in Aurora A‐high NSCLC patients. Targeting this pathway may restore T‐cell viability and improve therapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The 1st Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Inner Mongolia People's Hospital, Baotou Medical College, Inner Mongolia University of Science& Technology, Hohhot, Inner Mongolia Autonomous Region, China.
- Jiujiang No. 1 People's Hospital, Jiujiang, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Z., Chen, B., Zheng, K., Wan, D., & Kuang, P. (2026). Aurora A‐Mediated Exosomal Secretion of miR ‐644a Promotes T‐Lymphocyte Apoptosis Through the NOXA / p4E ‐ BP1 / MCL ‐1 Pathway. Clinical and Experimental Pharmacology and Physiology, 53(6). https://doi.org/10.1111/1440-1681.70132
Vancouver
Zhou Z, Chen B, Zheng K, Wan D, Kuang P. Aurora A‐Mediated Exosomal Secretion of miR ‐644a Promotes T‐Lymphocyte Apoptosis Through the NOXA / p4E ‐ BP1 / MCL ‐1 Pathway. Clinical and Experimental Pharmacology and Physiology. 2026;53(6). doi:10.1111/1440-1681.70132
BibTeX
@article{Zhou2026,
author = {Zhou, Ziyi and Chen, Biao and Zheng, Kaiyue and Wan, Dewen and Kuang, Peng},
title = {Aurora A‐Mediated Exosomal Secretion of miR ‐644a Promotes T‐Lymphocyte Apoptosis Through the NOXA / p4E ‐ BP1 / MCL ‐1 Pathway},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2026},
volume = {53},
number = {6},
doi = {10.1111/1440-1681.70132}
}
EUVIMED